Indefinite Delivery Contract SPE2DR25D2207

Award Date 9/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers. The contract has a 30-month base period with three 30-month option periods, for a total potential period of performance through December 2036. The IDC aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical and medical supply support to various DoD customers. The IDC covers a 30-month base period with three 30-month option periods, for a total period of performance through December 2036. The contract aims to establish Prime Vendor Contracts for...
The Defense Logistics Agency (DLA) Troop Support Medical awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods, for a total potential period of performance through December 2036. The contract aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to Amerisourcebergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. The contract has a 30-month base period and three 30-month option periods. The contract aims to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to support the Defense Health Agency (DHA),...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded an Indefinite Delivery Contract (IDC) valued at $9,999,999,999 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which runs through December 2036, is an unrestricted, fully competitive acquisition to establish Prime Vendor Contracts for the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V). The purpose of the PPV-G GEN V program is to...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC, which runs through December 2036, will serve as the primary vehicle for procuring specialty medications, brand-name and generic drugs, vaccines,...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. This single-award IDC will serve as the primary vehicle for the DLA to procure brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and other critical medical...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $999,999,999 Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. This single-award IDC has a 30-month base period and three 30-month option periods, for a total period of performance through December 2036. The contract aims to establish Prime Vendor Contracts for the DLA Troop Support's Pharmaceutical Prime...
The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The $999,999,999 IDC has a 30-month base period and three 30-month option periods, totaling a potential 10-year period of performance through December 2036. The contract aims to establish Prime Vendor Contracts for the...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $999,999,999 Indefinite Delivery Contract (IDC) to AmerisourceBergen Drug Corp to provide pharmaceutical products and medical supplies to support military healthcare programs globally. This single-award IDC, with a base period through December 2026 and three 30-month option periods, is part of the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) procurement. The IDC encompasses a comprehensive range of...

The Defense Logistics Agency (DLA) Troop Support Medical Supply Chain has awarded an Indefinite Delivery Contract (IDC) valued at $999,999,999 to AmerisourceBergen Drug Corp to provide worldwide pharmaceutical support to various DoD customers. This contract, referred to as the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), covers a broad range of pharmaceutical and medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract has a 30-month base period and three 30-month option periods, for a total potential period of performance through December 2036.

This IDC serves as the primary vehicle for DLA to procure essential pharmaceutical and medical supplies to support military healthcare programs globally, including for military treatment facilities, veterans' healthcare, and other federal medical institutions. The contract was awarded through an unrestricted, fully competitive solicitation process, with the intent to make multiple regional awards to ensure resiliency and access to vital pharmaceuticals during contingencies or natural disasters. The contract utilizes a Lowest Price Technically Acceptable (LPTA) evaluation approach, with the possibility of a reverse auction to determine the final distribution fees.

Generated 6/6/25, 10:09 AM